COVID-19 Project Team: Difference between revisions

Jump to navigation Jump to search
Sahar Memar Montazerin (talk | contribs)
No edit summary
Sahar Memar Montazerin (talk | contribs)
No edit summary
Line 16: Line 16:
**Sara Haddadi
**Sara Haddadi
* Dermatologic Disorders of COVID-19 Team Members
* Dermatologic Disorders of COVID-19 Team Members
 
* Hematologic disorders and COVID-19 Team Members
* Nephrologic Disorders and COVID-19 Team Members
* Nephrologic Disorders and COVID-19 Team Members
**[[User:Gurman4sandhu|Gurmandeep Singh Sandhu, M.B.B.S.]]
**[[User:Gurman4sandhu|Gurmandeep Singh Sandhu, M.B.B.S.]]
Line 29: Line 29:
**[[User:Neepa Shah|Neepa Shah, M.B.B.S.]]
**[[User:Neepa Shah|Neepa Shah, M.B.B.S.]]
* Radiologic Manifestations of COVID-19 Team Members
* Radiologic Manifestations of COVID-19 Team Members
* Hematologic disorders and COVID-19 Team Members


*[[User:Aisha Adigun|Aisha Adigun, M.D.]]
 
*[[User:Bosky Soni|Bosky Soni, M.D., MPH]]
**[[User:Aisha Adigun|Aisha Adigun, M.D.]]
*
**[[User:Bosky Soni|Bosky Soni, M.D., MPH]]
*
 
*
**Nuha Abdullah Alhowthi  
*
**Oluwabusola Adogba
*
 
*
*Nuha Abdullah Alhowthi  
*Oluwabusola Adogba
*
*[[User:Rija Gul|Rija Gul, M.D.]]
*[[User:Rija Gul|Rija Gul, M.D.]]
*[[User:Roukoz Abou Karam|Roukoz Abou Karam, M.D.]]
*[[User:Roukoz Abou Karam|Roukoz Abou Karam, M.D.]]

Revision as of 17:16, 10 June 2020

COVID-19 Project
Introduction
Team
Meetings' Summary
Topics
Ongoing Clinical Trials

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]

Meet The Team

Associate Editor(s)-in-Chief:


    • Nuha Abdullah Alhowthi
    • Oluwabusola Adogba